Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preclinical ex Vivo Patient-derived 3D Cultures for the Prediction of Prostate Cancer Treatment Response

NCT07004582 is registered in ClinicalTrials.gov with Maastricht Radiation Oncology as lead sponsor.

NCT NCT07004582
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07004582 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preclinical ex Vivo Patient-derived 3D Cultures for the Prediction of Prostate Cancer Treatment Response
Lead sponsor
Maastricht Radiation Oncology
Phase
Observational
Overall status
Recruiting
Start date
March 15, 2026
Completion date
December 30, 2031
Enrollment
600 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

advanced prostate cancer, prostate cancer, prostate cancer metastatic disease, prostate cancer recurrent